DURECT (DRRX) Insider Trading & Ownership $0.59 -0.02 (-3.56%) As of 05/21/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DURECT (NASDAQ:DRRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.20%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$116,064.53Number OfInsiders Selling(Last 3 Years)0 Get DRRX Insider Trade Alerts Want to know when executives and insiders are buying or selling DURECT stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DRRX Insider Buying and Selling by Quarter DURECT Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/19/2022Judith J RobertsonDirectorBuy9,412$0.85$8,000.20 8/17/2022Judith J RobertsonDirectorBuy10,189$0.85$8,660.65 8/11/2022Gail J MaderisDirectorBuy24,796$0.70$17,357.20 8/9/2022Gail J MaderisDirectorBuy70,307$0.64$44,996.48 5/26/2022Judith J RobertsonDirectorBuy65,000$0.39$25,350.00 5/24/2022Mohammad AzabDirectorBuy30,000$0.39$11,700.00 (Data available from 1/1/2013 forward) DRRX Insider Trading Activity - Frequently Asked Questions Who is on DURECT's Insider Roster? The list of insiders at DURECT includes Gail J Maderis, Judith J Robertson, and Mohammad Azab. Learn more on insiders at DRRX. What percentage of DURECT stock is owned by insiders? 3.20% of DURECT stock is owned by insiders. Learn more on DRRX's insider holdings. DURECT Key ExecutivesDr. James E. Brown D.V.M. (Age 67)Co-Founder, CEO, President & Director Compensation: $633.46kMr. Timothy M. Papp M.B.A. (Age 48)CFO & Secretary Compensation: $427.62kDr. Norman L. Sussman M.D. (Age 71)Chief Medical Officer Compensation: $471.71kMs. Judy R. Joice (Age 67)Senior Vice President of Operations & Corporate Quality Assurance Compensation: $451.82kDr. WeiQi Lin M.D.Ph.D., Executive VP of Research & Development and Principal ScientistMr. Keith L. Lui M.B.A.Senior Vice President of Business Development, Commercial & Medical AffairsMs. Jian Li M.B.A. (Age 54)Senior VP of Finance, Corporate Controller & Secretary Compensation: $297.08kDr. Su Il Yum Ph.D. (Age 85)Executive Officer Compensation: $331.74k More Insider Trading Tools from MarketBeat Related Companies IZTC Insider Trading OCX Insider Trading TCRX Insider Trading INZY Insider Trading CRBU Insider Trading ADAP Insider Trading XCUR Insider Trading EPIX Insider Trading ELUT Insider Trading STRO Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite This page (NASDAQ:DRRX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DURECT Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share DURECT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
